Featured Articles

Astellas Pharma and Vical asserted the negative results for Phase 3 Helios Clinical Trial for ASP0113, an investigational DNA vaccine being developed for cytomegalovirus…
Read More...

Immuno-oncology company, Agenus asserted the launch of its proprietary anti- CTLA4 (AGEN1884) and anti-PD1 (AGEN2034) antibodies. The open-label Phase 1/2 study is designed to evaluate…
Read More...

Amgen affirms optimistic outcomes for Phase 3b LIBERTY study evaluating the efficacy and safety of Aimovig (erenumab) 140 mg in patients with episodic migraine who had experienced two…
Read More...

AstraZeneca and Merck asserted the sanctioning of LYNPARZA tablets for patients with platinum-sensitive relapsed ovarian cancer, regardless of their BRCA mutation status, who responded…
Read More...

Company developing intratumoral cancer immunotherapies, OncoSec Medical claimed the observations of preliminary Clinical trial study related to its OMS-1140 ImmunoPulse 1L-12 in…
Read More...

Privately-held start-up developing VasQ, Laminate Medical Technologies declared the roll- out of its FDA pivotal study in the US. VasQ is an implanted blood vessel external support…
Read More...

Molecule discovery specialist X-Chem, proclaimed a remarkable extension of their present drug discovery collaboration with AstraZeneca. The agreement focuses on the synthesis and…
Read More...

Eiger Biopharmaceuticals displaying forte in development and commercialization of targeted therapies for rare diseases declared negative results for Phase 2 LIBERTY study in pulmonary…
Read More...

Marina Biotech, a biopharmaceutical company committed to the development and commercialization of advanced therapeutics for hypertension, arthritis, pain and oncology embarked on a…
Read More...

US Food and Drug Administration (FDA) has assured priority review of Novartis supplemental Biological License Application (sBLA) for Kymriah suspension for intravenous infusion,…
Read More...

Neurim Pahrmaceuticals and BIOCODEX undertake a license agreement that enlists the fact that BIOCODEX will possess the exclusive marketing rights to market Neurim's Rx paediatric…
Read More...

Vantage Cancer Care Network into providing integrated cancer Care ventured into an agreement with Alliance Cancer Specialists, PC ensuring extensive delivery of top-notch Oncology Care…
Read More...

Sarah Cannon Research Institute and South Texas Research Accelerated Therapeutics moved to collaborate ensuring augmenting their globally acclaimed phase I drug development programs…
Read More...

Utilizing advanced analytics to offer workflow solutions and apps that advocate support solutions paving way for undisputed integration and analysis of in-vivo and in-vitro data, …
Read More...

U.S Diagnostics confirms distribution of the INFINITY Blood Glucose Monitoring System across Western Africa. Located in New York, INFINITY Blood Glucose Monitoring System…
Read More...

U.S Stem Cell, Inc. claimed to be a leader in the development of proprietary stem cell therapies asserted accomplishing the target of 10,000 kit sales of proprietary Adipocell product,…
Read More...

Global biotech company committed to delivering transformative therapies to patients with orphan dermatologic and other underserved conditions, Castle Creek Pharmaceuticals confirmed…
Read More...

Fresenius Kabi confirmed the availability of Bortezomib for injection  in the United States. Fresenius Kabi Bortezomib for Injection is available as a single dose vial containing 3.5 mg…
Read More...

GSK asserted that it has received approval from the US FDA center for biologics Evaluation and Research thereby hinting at the usage of FLUARIX QUADRIVALENT in persons 6 months and…
Read More...

SkinCure Oncology declared delivery of its  46th image guided superficial radiation therapy system. SkinCure Oncology is into providing a turnkey model for delivery of such systems.…
Read More...